Guided Therapeutics (OTCMKTS:GTHP) Stock Price Up 1.3% – What’s Next?

Shares of Guided Therapeutics, Inc. (OTCMKTS:GTHP) shot up 1.3% on Wednesday . The stock traded as high as $0.16 and last traded at $0.16. 606 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 20,770 shares. The stock had previously closed at $0.16.

Guided Therapeutics Stock Performance

The business’s fifty day simple moving average is $0.17 and its 200-day simple moving average is $0.15. The firm has a market capitalization of $9.88 million, a PE ratio of -5.40 and a beta of 0.49.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.